These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25472037)

  • 1. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
    Sun WX; Chen YH; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Shen XL; He XF; Wu LX; Wei W; Zhang L
    Mol Genet Genomics; 2015 Apr; 290(2):709-25. PubMed ID: 25472037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene and lung cancer risk: a meta-analysis.
    Bu ZB; Ye M; Cheng Y; Wu WZ
    Asian Pac J Cancer Prev; 2014; 15(14):5673-9. PubMed ID: 25081684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
    Zeng Y; Jiang HY; Wei L; Xu WD; Wang YJ; Wang YD; Liu C
    Asian Pac J Cancer Prev; 2015; 16(16):7249-54. PubMed ID: 26514519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.
    Zhenzhen L; Xianghua L; Ning S; Zhan G; Chuanchuan R; Jie L
    Eur J Cancer Prev; 2013 Nov; 22(6):607-19. PubMed ID: 23462460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.
    Ma Z; Guo W; Gong T; Niu HJ; Wang RW; Jiang YG
    Tumour Biol; 2014 Mar; 35(3):2253-7. PubMed ID: 24293373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies.
    Tian Z; Li YL; Zhao L; Zhang CL
    Gene; 2013 Jul; 524(2):168-74. PubMed ID: 23628800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CYP1A2 gene variants -163 C/A (rs762551) and -3860 G/A (rs2069514) and bladder cancer susceptibility.
    Iqbal MS; Sardar N; Peng K; Almutairi LA; Duan X; Tanvir F; Attia KA; Zeng G; Gu D
    BMC Cancer; 2024 Jul; 24(1):880. PubMed ID: 39039510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of correlation between the CYP1A2 -3860 G > A polymorphism and lung cancer risk.
    Ren J; He BZ; Zhang TS; Lu SP; Yan T
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.
    Vukovic V; Ianuale C; Leoncini E; Pastorino R; Gualano MR; Amore R; Boccia S
    BMC Cancer; 2016 Feb; 16():83. PubMed ID: 26865042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
    Chen PF; He XF; Huang GH; Wang W; Qiu ZH
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population.
    Matakova T; Halasova E; Dzian A; Hruby R; Halasa M; Javorka K; Skerenova M
    Adv Exp Med Biol; 2016; 911():23-32. PubMed ID: 26987327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
    He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
    PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
    Song YL; Wang L; Ren JC; Xu ZH
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
    Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies.
    Wang H; Zhang Z; Han S; Lu Y; Feng F; Yuan J
    BMC Cancer; 2012 Nov; 12():528. PubMed ID: 23157985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. quantitative assessment of the influence of cytochrome P450 1A2 gene polymorphism and colorectal cancer risk.
    Zhao Y; Chen ZX; Rewuti A; Ma YS; Wang XF; Xia Q; Fu D; Han YS
    PLoS One; 2013; 8(8):e71481. PubMed ID: 23951174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study.
    Pavanello S; Fedeli U; Mastrangelo G; Rota F; Overvad K; Raaschou-Nielsen O; Tjønneland A; Vogel U
    Cancer Genet; 2012 Jun; 205(6):278-84. PubMed ID: 22749033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the CYP1A2 -163C>A polymorphism and lung cancer risk.
    Deng SQ; Zeng XT; Wang Y; Ke Q; Xu QL
    Asian Pac J Cancer Prev; 2013; 14(5):3155-8. PubMed ID: 23803095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men.
    Singh AP; Pant MC; Ruwali M; Shah PP; Prasad R; Mathur N; Parmar D
    Cancer Biomark; 2010-2011; 8(6):351-9. PubMed ID: 22072123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.